Sphera Funds Management logo

Sphera Funds Management

Asia, Tel Aviv, Israel, Tel Aviv

Description

Sphera Funds Management is an Israeli based fund manager, established in December 2003. The Fund is specializing in long-short equity

Investor Profile

Sphera Funds Management has made 13 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (54%)
  • Post Ipo Equity (23%)
  • Series Unknown (8%)
  • Series D (8%)
  • Series E (8%)

Country Focus

  • United States (69%)
  • Denmark (8%)
  • Canada (8%)
  • France (8%)
  • Germany (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Health Diagnostics
  • Wellness
  • Oncology
  • Alternative Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sphera Funds Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 5
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
RTW Investments
North America, New York, United States, New York
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 3
Jennison Associates
North America, New York, United States, New York
Co-Investments: 3
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3

Which angels does Sphera Funds Management often collaborate with?

SH
North America, California, United States, Santa Monica
Shared Deals: 1

What are some of recent deals done by Sphera Funds Management?

Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series UnknownJun 22, 2021
Amount Raised: $41,500,000
Field Trip Health

Toronto, Ontario, Canada

Field Trip Health is providing simple, evidence-based therapies for healing and heightening engagement with the world.

Alternative MedicineHealth CareTherapeuticsWellness
Post Ipo EquityMar 17, 2021
Amount Raised: $76,682,474
Galecto

Copenhagen, Hovedstaden, Denmark

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

BiotechnologyHealth CareHealth Diagnostics
Series DSep 25, 2020
Amount Raised: $64,000,000
ESCAPE Bio

South San Francisco, California, United States

ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.

BiotechnologyHealth CareMedical
Series BSep 14, 2020
Amount Raised: $73,000,000
C4 Therapeutics

Cambridge, Massachusetts, United States

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Health DiagnosticsMedicalTherapeutics
Series BJun 16, 2020
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMar 17, 2020
Amount Raised: $104,000,000
Passage Bio

Philadelphia, Pennsylvania, United States

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BSep 4, 2019
Amount Raised: $110,000,000
Oncorus

Cambridge, Massachusetts, United States

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

BiotechnologyMedicalOncologyTherapeutics
Series BAug 21, 2019
Amount Raised: $79,500,000
Stoke Therapeutics

Bedford, Massachusetts, United States

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BOct 23, 2018
Amount Raised: $90,000,000
Selecta Biosciences

Watertown, Massachusetts, United States

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

BiopharmaBiotechnologyPharmaceutical
Series ESep 8, 2015
Amount Raised: $38,000,000